The stock has a 36-month beta value of 0.91. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for BDSX is 74.16M, and at present, short sellers hold a 1.42% of that float. On May 19, 2025, the average trading volume of BDSX was 863.57K shares.
BDSX) stock’s latest price update
Biodesix Inc (NASDAQ: BDSX) has seen a rise in its stock price by 36.91 in relation to its previous close of 0.22. However, the company has experienced a -18.95% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-15 that LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 Annual Meeting in Montreal, Quebec and at the American Thoracic Society (ATS) 2025 International Conference in San Francisco, California.
BDSX’s Market Performance
BDSX’s stock has fallen by -18.95% in the past week, with a monthly drop of -45.59% and a quarterly drop of -69.42%. The volatility ratio for the week is 37.90% while the volatility levels for the last 30 days are 19.38% for Biodesix Inc The simple moving average for the past 20 days is -31.60% for BDSX’s stock, with a -75.22% simple moving average for the past 200 days.
Analysts’ Opinion of BDSX
Craig Hallum gave a rating of “Buy” to BDSX, setting the target price at $3 in the report published on July 26th of the previous year.
BDSX Trading at -48.80% from the 50-Day Moving Average
After a stumble in the market that brought BDSX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.24% of loss for the given period.
Volatility was left at 19.38%, however, over the last 30 days, the volatility rate increased by 37.90%, as shares sank -45.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -64.56% lower at present.
During the last 5 trading sessions, BDSX fell by -18.95%, which changed the moving average for the period of 200-days by -82.18% in comparison to the 20-day moving average, which settled at $0.4405. In addition, Biodesix Inc saw -80.31% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BDSX starting from Vazquez Chris, who sale 112 shares at the price of $0.36 back on May 12 ’25. After this action, Vazquez Chris now owns 18,113 shares of Biodesix Inc, valued at $40 using the latest closing price.
Vazquez Chris, the Chief Accounting Officer of Biodesix Inc, sale 112 shares at $0.35 during a trade that took place back on May 13 ’25, which means that Vazquez Chris is holding 18,001 shares at $40 based on the most recent closing price.
Stock Fundamentals for BDSX
Current profitability levels for the company are sitting at:
- -0.44 for the present operating margin
- 0.59 for the gross margin
The net margin for Biodesix Inc stands at -0.54. The total capital return value is set at -0.45. Equity return is now at value -1454.41, with -46.61 for asset returns.
Based on Biodesix Inc (BDSX), the company’s capital structure generated 0.85 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 5.63. The interest coverage ratio of the stock is -8.05.
Currently, EBITDA for the company is -34.5 million with net debt to EBITDA at -1.56. When we switch over and look at the enterprise to sales, we see a ratio of 1.19. The receivables turnover for the company is 9.75for trailing twelve months and the total asset turnover is 0.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.22.
Conclusion
To sum up, Biodesix Inc (BDSX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
